CAS 1259028-99-3

BTT 3033

CAS: 1259028-99-3

Formel: C₂₃H₂₀FN₅O₃S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 465.5000

Ref: IN-DA00IMDT

BTT-3033

CAS: 1259028-99-3

BTT-3033

Reinheit: ≥98%

Molekulargewicht: 465.5g/mol

Ref: 54-BUP06360

BTT 3033

CAS: 1259028-99-3

Formel: C₂₃H₂₀FN₅O₃S

Reinheit: >96.0%(HPLC)

Farbe und Form: White to Light yellow to Light orange powder to crystal

Molekulargewicht: 465.50

Ref: 3B-B5415

BTT-3033

CAS: 1259028-99-3

BTT-3033 is an α2β1 inhibitor that induces apoptosis and can be used to study prostate cancer, inflammation and cardiovascular disease.

Formel: C₂₃H₂₀FN₅O₃S

Reinheit: 98.91% - 99.36%

Farbe und Form: Solid

Molekulargewicht: 465.5

Ref: TM-T26917

BTT 3033

Kontrolliertes Produkt

CAS: 1259028-99-3

Formel: C₂₃H₂₀FN₅O₃S

Farbe und Form: Neat

Molekulargewicht: 465.5

Ref: TR-B689365

BTT 3033

CAS: 1259028-99-3

BTT 3033 is a small molecule that interacts with collagen and has been shown to inhibit the proliferation of prostate cancer cells. BTT 3033 is a novel agent that binds to extracellular matrix proteins such as collagen, laminin, fibronectin, and vitronectin. This binding prevents cell adhesion and migration, leading to an inhibition of cell proliferation. BTT 3033 has also been shown to down regulate the expression of various marker proteins, such as CD44, which is associated with tumor progression in prostate cancer. The mechanism for this action may involve an interaction between BTT 3033 and collagen as well as an alteration in the function of cells by inhibiting cell signaling pathways involved in cell growth and survival.

Formel: C₂₃H₂₀FN₅O₃S

Reinheit: Min. 95%

Molekulargewicht: 465.5 g/mol

Ref: 3D-JAC02899